John Moore
General Counsel at EDGEWISE THERAPEUTICS, INC.
Net worth: 51 837 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kevin Koch | M | 63 | 23 years | |
| R. Carruthers | M | 66 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 24 years |
| Bronson Crouch | M | 51 | 6 years | |
| Katharine Martin | F | 61 |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | 25 years |
| Sandeep Laumas | M | 56 | 4 years | |
| Peter Thompson | M | 64 | 7 years | |
| Alan Russell | M | 54 | 7 years | |
| Badreddin Edris | M | 37 | 7 years | |
| Jonathan Fox | M | 66 | 1 years | |
| Gwendolyn Binder-Scholl | M | 49 | 4 years | |
| Jon Root | M | 64 | 5 years | |
| Neil Gibson | M | 67 | 4 years | |
| Robert Hawkins | M | 69 | 4 years | |
| George Matcham | M | 72 | 6 years | |
| Laura Brege | F | 66 | 4 years | |
| Richard McGaughy | M | 52 | 4 years | |
| Behrad Derakhshan | M | 44 | 4 years | |
| Leslie Leinwand | M | - | - | |
| Marc Semigran | M | 67 | 2 years | |
| Joanne Donovan | M | 67 | 3 years | |
| Mark Dudley | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David L. Snitman | M | 72 | 17 years | |
| John Josey | M | 63 | 21 years | |
| Sumita Ray | F | 50 | 1 years | |
| Aaron Symanski | M | - |
University of Illinois At Urbana–Champaign
| 8 years |
| Jon Congleton | M | 60 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 3 years |
| Charles Baum | M | 65 | 5 years | |
| Jason Haddock | M | 54 | 3 years | |
| Jack Nielsen | M | 60 | 4 years | |
| Thilo Schroeder | M | 42 | 5 years | |
| Curtis Oltmans | M | 60 | 2 years | |
| Shalini Sharp | F | 49 | 2 years | |
| Jack Mahler | M | - |
The University of North Carolina at Chapel Hill
| 8 years |
| Andrew Robbins | M | 48 | 7 years | |
| John Orwin | M | 62 | 7 years | |
| Ron Squarer | M | 57 | 7 years | |
| Evan Loh | M | 65 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 5 years |
| Cynthia Smith | F | 55 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 years |
| Gwen A. Fyfe | M | 72 | 7 years | |
| Liam Ratcliffe | M | 60 | 2 years | |
| Robin L. Rains | F | - |
The University of North Carolina at Chapel Hill
| 6 years |
| Shawn J. Lindquist | M | 54 |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | 7 years |
| Harischandra Abeygunawardena | M | 76 |
University of Illinois At Urbana–Champaign
| 3 years |
| John L. Zabriskie | M | 85 | 12 years | |
| Gil van Lunsen | M | 81 | 17 years | |
| Paul Sekhri | M | 65 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 years |
| David J. Horin | M | 56 | 1 years | |
| Melanie Levy | F | - |
UNC School of Law
| 8 years |
| Robert Conway | M | 70 | 13 years | |
| Anthony D. Piscopio | M | - | 8 years | |
| Kenneth Harrison | M | 44 | 4 years | |
| David R. Carr | M | - |
The University of North Carolina at Chapel Hill
| 8 years |
| Francis J. Bullock | M | 87 | 14 years | |
| Mark Lackner | M | 56 |
University of Illinois At Urbana–Champaign
| 5 years |
| Brent D. Barringer | M | 65 |
The University of North Carolina at Chapel Hill
| 7 years |
| Mark Portnoy | M | 60 |
The University of North Carolina at Chapel Hill
| 4 years |
| Mike Sodaro | M | - |
University of Illinois At Urbana–Champaign
| 4 years |
| Maher Hakim | M | - |
University of Illinois At Urbana–Champaign
| 2 years |
| Kevin E Howard | M | - |
University of Illinois At Urbana–Champaign
| 5 years |
| Herb Ormond | M | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Michael Gerard Carter | M | - |
The University of North Carolina at Chapel Hill
| 3 years |
| Randal Lewis | M | 57 |
University of Illinois At Urbana–Champaign
| 4 years |
| Dexter Tucker | M | - |
The University of North Carolina at Chapel Hill
| 3 years |
| Amanda Thomas | F | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Suwandi | M | 56 |
The University of North Carolina at Chapel Hill
| 4 years |
| David M. Truitt | M | 60 |
The University of North Carolina at Chapel Hill
| 4 years |
| Dan Krueger | M | - |
University of Illinois At Urbana–Champaign
| 4 years |
| Michael William Pennington | M | 62 |
The University of North Carolina at Chapel Hill
| 4 years |
| Courtney Spencer | F | 55 |
The University of North Carolina at Chapel Hill
| 4 years |
| David Fisher | M | 54 |
University of Illinois At Urbana–Champaign
| 4 years |
| Charles Carriere | M | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Mark Smith | M | 72 |
The University of North Carolina at Chapel Hill
| 4 years |
| Michael D. Platt | M | 63 |
The University of North Carolina at Chapel Hill
| 4 years |
| J. Kirkland | M | 59 |
The University of North Carolina at Chapel Hill
| 4 years |
| Vanessa Wittman | F | 56 |
The University of North Carolina at Chapel Hill
| 4 years |
| Robert Todd Joyce | M | 66 |
The University of North Carolina at Chapel Hill
| 4 years |
| James Williams | M | 59 |
The University of North Carolina at Chapel Hill
| 4 years |
| Ajit Dayal | M | 64 |
The University of North Carolina at Chapel Hill
| 2 years |
| Hal Eddins | M | - |
The University of North Carolina at Chapel Hill
| 5 years |
| William Henry Collier | M | - |
The University of North Carolina at Chapel Hill
| 4 years |
| James Babb | M | 59 |
The University of North Carolina at Chapel Hill
| 4 years |
| William Fine | M | 57 |
The University of North Carolina at Chapel Hill
| 4 years |
| Kim Cummings Carson | F | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Sallie Krawcheck | F | 59 |
The University of North Carolina at Chapel Hill
| 4 years |
| Julie H. Ocko | F | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Melissa Daniels | F | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Brian V. Caid | M | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Judy Brown | F | 55 |
University of Illinois At Urbana–Champaign
| 4 years |
| Lisa Caldwell | F | 63 |
The University of North Carolina at Chapel Hill
| 4 years |
| Raymond Zage | M | 54 |
University of Illinois At Urbana–Champaign
| 4 years |
| Tom McDermott | M | - |
The University of North Carolina at Chapel Hill
| 2 years |
| Jeff M. DeJesus | M | - |
University of Illinois At Urbana–Champaign
| 4 years |
| David Welch | M | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Chris Cecil | M | - |
The University of North Carolina at Chapel Hill
| 4 years |
| John P. Mitola | M | 59 |
University of Illinois At Urbana–Champaign
| 4 years |
| Guido Prestes Lemos | M | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Hans Hennig | M | 66 |
University of Illinois At Urbana–Champaign
| 4 years |
| Andrew J. Flint | M | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Tim Corbett | - | - |
The University of North Carolina at Chapel Hill
| 4 years |
| Bruce Emken | M | - |
University of Illinois At Urbana–Champaign
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Moore
- Personal Network
